How do Migratory Dendritic Cell Populations Control Immune Responses in the Intestine?
How do Migratory Dendritic Cell Populations Control Immune Responses in the Intestine?
批准号:
MR/K021095/1
负责人:
Simon Milling
金额:
$68.5万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The intestine has a surface area nearly one hundred times greater than the skin, and is exposed to many potentially dangerous micro-organisms. It requires effective immune responses to protect the intestine from infections, and the correct type of immune response must be made to control the different types of pathogen that may be encountered. On the other hand, immune responses must not be made against the large numbers of harmless bacteria and abundant food proteins that are also present in the intestine. When an inappropriate response occurs it can have serious consequences, leading to inflammatory bowel diseases or food allergy. A critical cell for controlling immune responses is the dendritic cell (DC). Many DCs are found in the intestine, where they actively gather information about their local environment, including about whether any micro-organisms have managed to cross the thin barrier of cells that separates food and "friendly bacteria" from the tissues of the body. Following a period of residence in the intestine of approximately 20 days, DCs migrate, in lymph, carrying information about the intestine to the immune cells in the local (mesenteric) lymph nodes (MLN). On reaching the MLN, DCs interact with T cells, key immune effector cells. This interaction not only controls whether an immune response will occur, but also determines which type of response will be generated. Understanding how DCs control these processes is important for the design of oral vaccines or prevention of inflammatory bowel diseases. However, the study of migrating DCs has been difficult because they cannot easily be separated or identified among the other cells in the MLNs and intestine. The best way to collect cells that are certain to be migrating DCs is by surgery, which is used to directly collect the DC-containing lymph. Previously this surgery has mostly been performed in large animals. We developed humane surgical techniques to collect migrating DCs from mice, and can therefore now use a wide variety of immunological techniques to analyse the DCs' functions. In our previous work, we have used these techniques to identify four different types of migrating intestinal DC, each of which generates different immune responses after interacting with T cells. Before we carried out these studies, it was thought that two of these DC types were unable to migrate from the intestine.With this application, we aim to continue our investigations into these different types of migrating DCs, and discover how their properties may be manipulated to control immune responses in the intestine- either to improve the efficiency of oral vaccines, or to help prevent or control intestinal inflammatory disease. Specifically, we will investigate how DCs control three different types of T cell immune responses in the intestine, using mouse models of these immune responses. We will examine the changes in the DCs that occur in each of the models, and also whether particular DC types are necessary or sufficient for inducing each of these responses. Finally, we will use these data to develop approaches for therapeutic modulation of intestinal immune responses.In summary: we have developed a unique array of techniques for the analysis of the functions of migrating intestinal DCs, and have used these to discover exciting new populations of cells with specific immunological functions. We will built on this strong foundation to discover how these DCs control the development of T cell responses in the intestine, and use these data to develop strategies for manipulating the intestinal immune response.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0068386
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Dunne KA, Allam A, McIntosh A, Houston SA, Cerovic V, Goodyear CS, Roe AJ, Beatson SA, Milling SW, Walker D, Wall DM]
通讯作者:
Wall DM
DOI:
10.1038/mi.2015.77
发表时间:
2016-03-01
期刊:
MUCOSAL IMMUNOLOGY
影响因子:
8
作者:
[Houston, S. A., Cerovic, V., Milling, S.]
通讯作者:
Milling, S.
DOI:
10.4049/jimmunol.1701254
发表时间:
2019-01-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Bravo-Blas A, Utriainen L, Clay SL, Kästele V, Cerovic V, Cunningham AF, Henderson IR, Wall DM, Milling SWF]
通讯作者:
Milling SWF
DOI:
10.1038/ncomms6862
发表时间:
2015-01-09
期刊:
NATURE COMMUNICATIONS
影响因子:
16.6
作者:
[Mackley, Emma C., Houston, Stephanie, Marriott, Clare L., Halford, Emily E., Lucas, Beth, Cerovic, Vuk, Filbey, Kara J., Maizels, Rick M., Hepworth, Matthew R., Sonnenberg, Gregory F., Milling, Simon, Withers, David R.]
通讯作者:
Withers, David R.
DOI:
10.3389/fimmu.2020.575967
发表时间:
2020
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Imperato JN, Xu D, Romagnoli PA, Qiu Z, Perez P, Khairallah C, Pham QM, Andrusaite A, Bravo-Blas A, Milling SWF, Lefrancois L, Khanna KM, Puddington L, Sheridan BS]
通讯作者:
Sheridan BS
共 6 条
Molecular mechanisms enabling cDC2s to control Th2 cell priming
-
批准号:MR/T030879/1
-
项目类别:Research Grant
-
资助金额:$68.22万
-
财政年份:2020
-
负责人:Simon Milling
-
依托单位:
Tissue-specific T cell migration in the intestine
-
批准号:MR/N023625/1
-
项目类别:Research Grant
-
资助金额:$94.97万
-
财政年份:2016
-
负责人:Simon Milling
-
依托单位:
The Functions of Migrating Dendritic Cells
-
批准号:G0900270/1
-
项目类别:Research Grant
-
资助金额:$48.36万
-
财政年份:2009
-
负责人:Simon Milling
-
依托单位:
The role of intestinal lymph DCs in intiating immune responses
-
批准号:BB/D012643/2
-
项目类别:Research Grant
-
资助金额:$9.41万
-
财政年份:2008
-
负责人:Simon Milling
-
依托单位:
The role of intestinal lymph DCs in intiating immune responses
-
批准号:BB/D012643/1
-
项目类别:Research Grant
-
资助金额:$31.71万
-
财政年份:2006
-
负责人:Simon Milling
-
依托单位:
国内基金
海外基金
登录
查看更多内容
复合菌剂在高DO下的好氧反硝化脱氮机制及工艺调控研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周月明
-
依托单位:
内生真菌DO14多糖PPF30调控铁皮石斛葡甘聚糖生物合成的机制
-
批准号:LZ23H280001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:吴令上
-
依托单位:
基于捕获“Do not eat me”信号的肺癌异质性分子功能可视化及机理研究
-
批准号:92259102
-
项目类别:重大研究计划
-
资助金额:60.00万元
-
批准年份:2022
-
负责人:许川
-
依托单位:
基于达文波特星形酵母Do18强化发酵的糟带鱼生物胺生物调控机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:涂传海
-
依托单位:
基于PO-DGT原理的沉积物微界面pH-DO-磷-重金属的精细化同步成像技术研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:韩超
-
依托单位:
CD38/cADPR信号通路异常促逼尿肌过度活动(DO)发生的分子机制及干预措施研究
-
批准号:81770762
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:郑霁
-
依托单位:
USP2介导RagA去泛素化稳定肿瘤细胞“Do not eat me”信号的机制研究
-
批准号:81773040
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2017
-
负责人:金国祥
-
依托单位:
抑制骨细胞来源Sclerostin蛋白对颌面部DO成骨的协同促进作用
-
批准号:81771104
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:钱玉芬
-
依托单位:
内生真菌DO14促铁皮石斛多糖成分积累的作用机制
-
批准号:31600259
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:吴令上
-
依托单位:
末次冰期东亚季风DO事件的定年、转型及亚旋回研究
-
批准号:40702026
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2007
-
负责人:陈仕涛
-
依托单位: